MedTrace Logo

Effect of Cold Atmospheric Plasma on Malassezia Folliculitis

NCT04886323 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2023-12-26

No results posted yet for this study

Summary

The cold atmospheric plasma may provide a new and effective method for the treatment of Malassezia folliculitis. The investigators conduct this randomized controlled trial to evaluate the effectiveness and safety of cold atmospheric plasma on Malassezia folliculitis. Participants entered this double-blind placebo-controlled trial will randomly assign to treatment with either cold atmospheric plasma or antifungal drugs. The differences of treatment effects of the two groups will be observed and compared.

Conditions

  • Malassezia Folliculitis

Interventions

DEVICE

Cold atmospheric plasma treatment device

Treat with cold atmospheric plasma treatment device.

DRUG

Itraconazole Capsules

Treat with Itraconazole capsules

Sponsors & Collaborators

  • Hefei CAS Ion Medical and Technical Devices Co.,Ltd

    collaborator UNKNOWN

  • The Second Hospital of Anhui Medical University

    lead OTHER

Principal Investigators

  • Chunjun Yang · The Second Hospital of Anhui Medical University

  • Na Wang · The Second Hospital of Anhui Medical University

  • Jingwen Wang · The Second Hospital of Anhui Medical University

  • Jing Gao · The Second Hospital of Anhui Medical University

  • Liyun Wang · The Second Hospital of Anhui Medical University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-08-03
Primary Completion
2023-12-17
Completion
2023-12-17

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04886323 on ClinicalTrials.gov